ATE211765T1 - Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen - Google Patents

Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen

Info

Publication number
ATE211765T1
ATE211765T1 AT95937853T AT95937853T ATE211765T1 AT E211765 T1 ATE211765 T1 AT E211765T1 AT 95937853 T AT95937853 T AT 95937853T AT 95937853 T AT95937853 T AT 95937853T AT E211765 T1 ATE211765 T1 AT E211765T1
Authority
AT
Austria
Prior art keywords
relates
biologically active
inhibitors
active substances
protease inhibitors
Prior art date
Application number
AT95937853T
Other languages
English (en)
Inventor
Gerard Voerman
Original Assignee
Vitaleech Bioscience N V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitaleech Bioscience N V filed Critical Vitaleech Bioscience N V
Application granted granted Critical
Publication of ATE211765T1 publication Critical patent/ATE211765T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT95937853T 1994-10-28 1995-10-27 Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen ATE211765T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94117053 1994-10-28
EP95103637 1995-03-14
PCT/EP1995/004223 WO1996013585A1 (en) 1994-10-28 1995-10-27 A novel family of protease inhibitors, and other biologic active substances

Publications (1)

Publication Number Publication Date
ATE211765T1 true ATE211765T1 (de) 2002-01-15

Family

ID=26135896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95937853T ATE211765T1 (de) 1994-10-28 1995-10-27 Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen

Country Status (11)

Country Link
US (1) US6239106B1 (de)
EP (1) EP0789764B1 (de)
JP (1) JP4278175B2 (de)
AT (1) ATE211765T1 (de)
AU (1) AU3870195A (de)
CA (1) CA2203827A1 (de)
DE (1) DE69524971T2 (de)
DK (1) DK0789764T3 (de)
ES (1) ES2171563T3 (de)
PT (1) PT789764E (de)
WO (1) WO1996013585A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270808B1 (en) 1995-11-13 2001-08-07 Gerard Voerman Anti-viral isolates obtainable from leeches
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
EP0875564A1 (de) * 1997-05-02 1998-11-04 Gerard Voerman Biologisch aktives Extrakt aus den Blutegeln 'Limnatis nilotica'
FR2763944B1 (fr) * 1997-06-03 2000-12-15 Centre Nat Rech Scient Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
JP4805461B2 (ja) * 1999-03-18 2011-11-02 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 血小板接着の阻止用タンパク質
KR20160054475A (ko) * 2013-08-05 2016-05-16 제라드 뵈르만 흡연의 해로운 영향을 감소시키는 신규의 수단
WO2016020070A1 (en) * 2014-08-05 2016-02-11 Gerard Voerman Mutants of leech derived neutrophil elastase inhibitors and uses thereof
CN105646702B (zh) * 2016-04-13 2019-03-01 中国科学院昆明动物研究所 菲牛蛭Kazal型胰蛋白酶抑制剂Bdellin-HM及其编码基因和应用
CN111315374A (zh) * 2017-08-27 2020-06-19 抗病毒科技有限责任公司 合成的赖氨酸类似物和模拟物的用于抗病毒用途的方法和组合物
US11262125B2 (en) * 2018-01-02 2022-03-01 Praxair Technology, Inc. System and method for flexible recovery of argon from a cryogenic air separation unit
WO2022232516A1 (en) * 2021-04-30 2022-11-03 The Regents Of The University Of California Cartilage treatment for use in eyelid reconstruction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL86857A (en) * 1988-06-24 1994-04-12 Yissum Res Dev Co Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
US5824641A (en) * 1993-04-09 1998-10-20 Bio-Technology General Corp Method of treating of preventing influenza

Also Published As

Publication number Publication date
DE69524971D1 (de) 2002-02-14
EP0789764B1 (de) 2002-01-09
ES2171563T3 (es) 2002-09-16
JPH10509589A (ja) 1998-09-22
AU3870195A (en) 1996-05-23
PT789764E (pt) 2002-06-28
US6239106B1 (en) 2001-05-29
WO1996013585A1 (en) 1996-05-09
EP0789764A1 (de) 1997-08-20
CA2203827A1 (en) 1996-05-09
DE69524971T2 (de) 2002-08-29
JP4278175B2 (ja) 2009-06-10
DK0789764T3 (da) 2002-04-22

Similar Documents

Publication Publication Date Title
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
ATE419275T1 (de) Antikörper gegen vla-4
ATE173478T1 (de) Varianten des pankreatischen rinder- trypsininhibitors, deren herstellung und verwendung
HK1043475A1 (en) Compositions and methods for treating infections using analogues of indolicidin
WO1999015549A3 (en) Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine
DK0762888T3 (da) Copolymer-1 forbedringer i præparater af copolymerer
ATE211765T1 (de) Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen
HK51197A (en) Platelet blocking peptides
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
ATE110742T1 (de) Peptid-verbindungen.
WO1996018646A3 (en) Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
FR2624854B1 (fr) Nouveaux sulfonamides du benzylidene camphre derivant d'aminoacides et leur application en cosmetique, notamment en tant que filtres solaires
EP1251176A3 (de) Expressionssysteme, die selbstspaltende Fusionsproteine verwenden sowie ein reduzierendes Polypeptid
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
NZ228208A (en) Eglin compounds (hurudin) and protease inhibitor pharmaceutical compositions
HUP0001184A2 (hu) "Basic Helix-Loop-Helix" (bHLH) családba tartozó polipeptidek és a megfelelő nukleinsav-szekvenciák
SE9402253D0 (sv) Process
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification